CRISTINA NUNEZ-CHRISTOPHER: Open Payments
NPI 1730215013 · NEW HYDE PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,811 in 43 payments from 14 companies in 2025. Trend: 2023 $490 · 2024 $294 · 2025 $1,811
Food & beverage: $1,811
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $416 |
| Ardelyx, Inc. | 7 | $227 |
| Janssen Biotech, Inc. | 4 | $190 |
| Madrigal Pharmaceuticals | 2 | $175 |
| ABBVIE INC. | 7 | $153 |
| Regeneron Healthcare Solutions, Inc. | 2 | $148 |
| Lilly USA, LLC | 4 | $140 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $82 |
| GENZYME CORPORATION | 1 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $68 |
Products named: General - Hemostasis, DUPIXENT, IBSRELA, TREMFYA, REZDIFFRA, General - Polypectomy, XIFAXAN, RINVOQ.
Industry payments across NY — which companies pay providers there.
